Bristol Myers Squibb to Take Part in the 7th Annual Truist Life Sciences Summit
Bristol Myers Squibb (NYSE: BMY) will participate in the 7th Annual Virtual Truist Life Sciences Summit on May 5, 2021. Senior executives Adam Lenkowsky and Winselow Tucker will discuss the company's oncology and hematology sectors during a live webcast at 8 a.m. ET. Interested investors and the public can access the session through the company’s investor website. An archived version will be available later that day.
- Participation in a prominent industry summit enhances visibility.
- Opportunity to engage with investors and the public.
- None.
Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in a fireside chat at the 7th Annual Virtual Truist Life Sciences Summit, which will be webcast on Wednesday, May 5, 2021. Adam Lenkowsky, Senior Vice President, General Manager of U.S. Oncology, Immunology and CV and Winselow Tucker, Senior Vice President, General Manager, U.S. Hematology will answer questions about the company at 8 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20210428005109/en/
FAQ
What is the date of the Truist Life Sciences Summit where BMY will participate?
Who will represent BMY at the Truist Life Sciences Summit?
How can I access the webcast of BMY's participation in the summit?
Is there an archived session of the BMY discussion at the summit?
